Overview


According to FutureWise analysis the market for DNA diagnostics in 2023 is US$ 24.87 billion, and is expected to reach US$ 48.2 billion by 2031 at a CAGR of 8.60%.

Medical diagnostics will be revolutionized by DNA diagnostics, a cutting-edge method that's set to revolutionize the field. Medical professionals can use this technique to identify various diseases, such as cancer, infectious diseases, and myogenic disorders, and determine the appropriate treatment for each. It is also used in the confirmation of clinical diagnoses and for prenatal diagnostics. The human genome project led to the discovery of disease-causing agents, making DNA diagnostics possible. DNA diagnostic platforms and techniques have been greatly improved through technological development. The technologies that incorporate DNA diagnostics include polymerase chain reaction, microarrays, sequencing technology, and mass spectrometry. These technologies are used to prepare samples, isolate DNA, etc. Technological advancements, which have led to improvements in DNA diagnostic methodologies, have driven the market for DNA diagnostics. Furthermore, DNA diagnostic methods are used in prenatal diagnosis and clinical confirmation, which has boosted market growth. DNA diagnostics will be positively impacted by the increased adoption of personalized medicines in the foreseeable future. A number of human diseases, including cancer, can be decoded using next-generation sequencing. Compared to traditional sequencing, next-generation sequencing is cheaper and faster. Its optimization could have a great impact on DNA diagnostics. Growing demand for newborn and prenatal screening to detect congenital abnormalities, and growing application of biobanking services, which include DNA testing as a crucial step in cord blood banking, are further reasons for the sector's growth. Another factor that is anticipated to fuel demand in the coming years is the increased preference of physicians for genetic testing to determine their patients' health at different stages of disease development. While the introduction of new technologies and their implementation is expected to bring growth to some degree, the high cost involved in R D is expected to hold back the industry.

FutureWise Market Research has instantiated a report that provides an intricate analysis of DNA Diagnostics Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the DNA Diagnostics Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  •  GE Healthcare
  •  454 Life Sciences
  •  Abbott Laboratories
  •  Beckman Coulter Inc.
  •  Bio-Rad Laboratories
  •  Thermo Fisher Scientific
  •  Illumina Inc.
  •  Cephide Inc.
  •  Hologic
  •  Transgenomic Inc.
  •  Siemens Healthcare
  •  Roche Diagnostics
  •  Qiagen
  •  Illumina
  •  Alere Inc.
  •  Affymetrix Inc.
  •  Agilent Technologies Inc.
  •  Dako
  •  Applied Biosystems Group

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Technology

  •  Microarrays based diagnostics
  •  PCR based diagnostics
  •  In-situ hybridization diagnostics
  •  NGS DNA diagnosis

By Application

  •  Prenatal DNA Carrier Screening
  •  Preimplantation Diagnosis
  •  Newborn Genetic Screening
  •  Infectious Disease Diagnostics
    •  HBV Diagnostic
    •  HCV Diagnostic
    •  HIV Diagnostic
    •  TB Diagnostic
    •  CT/NG Diagnostic
    •  HPV Diagnostic
    •  MRSA Diagnostic
    •  Others
  •  Oncology Diagnostics and Histopathology
  •  Identity Diagnostics and Forensics
  •  Pharmacogenomics Diagnostic Testing
  •  Drug Metabolism and P450 effects
  •  Others

By Region

  •  North America
  •  Europe
  •  Asia-Pacific
  •  Latin America
  •  Middle East and Africa

  •  Tier 1 players- established companies in the market with a major market share
  •  Tier 2 players
  •  Emerging players which are growing rapidly
  •  New Entrants

  •  Growth prospects
  •  SWOT analysis
  •  Key trends
  •  Key data-points affecting market growth

  •  To provide with an exhaustive analysis on the DNA Diagnostics Market By Technology, By Application and By Region.
  •  To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  •  To evaluate and forecast micro-markets and the overall market
  •  To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  •  To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  •  We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  •  The customization Mobility Care offered are free of charge with purchase of any license of the report
  •  You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   DNA Diagnostics Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of DNA Diagnostics Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   DNA Diagnostics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   DNA Diagnostics Market, By Technology Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Microarrays based diagnostics
        2. PCR based diagnostics
        3. In-situ hybridization diagnostics
        4. NGS DNA diagnosis

  • 8.   DNA Diagnostics Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Prenatal DNA Carrier Screening
        2. Preimplantation Diagnosis
        3. Newborn Genetic Screening
        4. Infectious Disease Diagnostics
         4.1. HBV Diagnostic
         4.2. HCV Diagnostic
         4.3. HIV Diagnostic
         4.4. TB Diagnostic
         4.5. CT/NG Diagnostic
         4.6. HPV Diagnostic
         4.7. MRSA Diagnostic
         4.8. Others
        5. Oncology Diagnostics and Histopathology
        6. Identity Diagnostics and Forensics
        7. Pharmacogenomics Diagnostic Testing
        8. Drug Metabolism and P450 effects
        9. Others

  • 9.   North America DNA Diagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America DNA Diagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe DNA Diagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific DNA Diagnostics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. GE Healthcare
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. 454 Life Sciences
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Abbott Laboratories
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Beckman Coulter Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Bio-Rad Laboratories
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Thermo Fisher Scientific
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Illumina Inc.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Cephide Inc.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Hologic
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
         10. Transgenomic Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
          11. Siemens Healthcare
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
         12. Roche Diagnostics
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
         13. Qiagen
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
          14. Illumina
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
         15. Alere Inc.
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
         16. Affymetrix Inc.
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
         17. Agilent Technologies Inc.
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
         18. Dako
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
         19. Applied Biosystems Group
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients